ZDAI:NASDAQDirectBooking Technology Co., Ltd. Analysis
Data as of 2026-05-12 - not real-time
$1.98
Latest Price
8/10Risk
Risk Level: High
Executive Summary
DirectBooking Technology (ZDAI) is trading at $1.98, well below its DCF fair value of $7.91, suggesting a substantial valuation gap. The stock sits beneath its 20‑day, 50‑day and 200‑day SMAs (2.62, 3.41 and 6.37 respectively), confirming a bearish technical stance. Momentum indicators are mixed: RSI is low at 27.3 (oversold) while the MACD histogram is marginally positive, hinting at a possible short‑term bounce. Volume is on a decreasing trend and the 30‑day volatility is extreme at 108%, amplifying price uncertainty. Fundamental metrics are weak – revenue fell 43%, gross margin is only 2.3%, operating margin is –94%, and the company carries $4.12 M of debt with a debt‑to‑equity ratio of 84%. Recent shareholder approval of an extraordinary general meeting to enhance the share capital structure could provide a path to recapitalisation, but execution risk remains high.
The high beta of 1.35 indicates sensitivity to market moves, and liquidity is thin given a market cap of $15.9 M and declining trading volume. Cash reserves are modest ($0.17 M) versus debt, and free cash flow, though positive, is insufficient to offset the operating losses. No dividend is paid, making dividend sustainability a non‑issue. Overall, the stock is severely undervalued from a pure valuation lens but beset by operational distress, sector cyclicality, and significant regulatory and geographic exposure.
The high beta of 1.35 indicates sensitivity to market moves, and liquidity is thin given a market cap of $15.9 M and declining trading volume. Cash reserves are modest ($0.17 M) versus debt, and free cash flow, though positive, is insufficient to offset the operating losses. No dividend is paid, making dividend sustainability a non‑issue. Overall, the stock is severely undervalued from a pure valuation lens but beset by operational distress, sector cyclicality, and significant regulatory and geographic exposure.
Market Outlook
Short Term
< 1 yearCautious
Model confidence: 7/10
Key Factors
- Bearish technical positioning below all major SMAs
- Decreasing volume and extreme short‑term volatility
- Continued operating losses and high debt load
Medium Term
1–3 yearsNeutral
Model confidence: 5/10
Key Factors
- Potential capital restructuring from recent shareholder resolution
- Persistent negative margins and weak cash generation
- Undervaluation relative to DCF offering upside if turnaround succeeds
Long Term
> 3 yearsPositive
Model confidence: 4/10
Key Factors
- Significant valuation discount to intrinsic value
- Opportunity for strategic overhaul of capital structure
- Long‑run exposure to Hong Kong construction demand despite current headwinds
Key Metrics & Analysis
Financial Health
Revenue Growth-43.20%
Profit Margin-81.83%
ROE-207.30%
ROA-60.76%
Debt/Equity84.27
P/B Ratio0.7
Op. Cash Flow$515.1K
Free Cash Flow$5.1M
Industry P/E30.2
Technical Analysis
TrendBearish
RSI27.3
Support$1.74
Resistance$11.48
MA 20$2.62
MA 50$3.41
MA 200$6.37
MACDBullish
VolumeDecreasing
Fear & Greed Index87.98
Valuation
Fair Value$7.91
GradeUndervalued
TypeValue
Risk Assessment
Beta1.35
Volatility107.74%
Sector RiskMedium
Reg. RiskHigh
Geo RiskHigh
Currency RiskMedium
Liquidity RiskHigh
Similar Tickers
ZKH
ZKH Group Limited
STOCKZJYL
JIN MEDICAL INTERNATIONAL LTD.
STOCKZJK
ZJK Industrial Co., Ltd.
STOCKZIP
ZipRecruiter, Inc.
STOCKZIONP
Zions Bancorporation N.A. - Depositary Shares each representing a 1/40th ownership interest in a share of Series A Floating-Rate Non-Cumulative Perpetual Prefer
STOCKZION
Zions Bancorporation N.A.
STOCKThis analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.